St. Jude receives EU clearance for cardiac mapping system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

St. Jude Medical has received European CE Mark approval of its EnSite Velocity Cardiac Mapping system, which is designed to help physicians more efficiently diagnose and deliver therapy to treat abnormal heart rhythms.

With new hardware and software, the St. Paul, Minn.-based company said its system offers set-up and connections, an intuitive software interface and includes two new capabilities: the OneMap tool and RealReview function.

The OneMap tool enables physicians to create a detailed cardiac model and electrical map using multiple catheters and electrodes. The RealReview function provides real-time, side-by-side views of the live procedure and previously recorded portions of the procedure. The EnSite Velocity System is used in minimally invasive electrophysiology procedures.